China Resources Sanjiu product joins national medical insurance drug catalogue

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. announced that its product, Yiqi Qingfei Granules, has been successfully included in the "National Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalogue (2025 Edition)" through negotiation. This inclusion follows the drug's registration certificate, issued by the National Medical Products Administration in January 2025.

Yiqi Qingfei Granules, a traditional Chinese medicine preparation, is an "Qi-invigorating and Yin-nourishing" agent. It is indicated for short-term symptoms after an illness, particularly for conditions like fatigue, shortness of breath after activity, dry cough with little phlegm, and sore throat, targeting qi and yin deficiency with spleen dysfunction and uneliminated pathogens.

The agreement's validity period runs from January 1, 2026, to December 31, 2027. While this marks the product's first inclusion in the national medical insurance directory, the company anticipates no significant short-term impact on its operating performance. However, it is expected to enhance China Resources Sanjiu's product portfolio in the respiratory field and strengthen its leadership in the category.